Purchase Order W9124926PA005

The U.S. Army Criminal Investigation Command (CID) awarded a firm fixed-price purchase order valued at $267,622 to Qiagen, LLC for molecular diagnostics products and services, effective January 1, 2026, with completion by December 31, 2026. This child contract, issued without set-aside designation, will be performed at Fort Gillem, Georgia. Qiagen, LLC, a Germantown, Maryland-based manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions, is a foreign-owned for-profit company specializing in DNA/RNA extraction kits, genomic analysis tools, and sample preparation instrumentation that support biomedical research, clinical diagnostics, and law enforcement operations across federal agencies.

This purchase order represents a task order against Qiagen's existing contract vehicles and reflects the company's established role as a preferred supplier to the Department of Defense and Defense Health Agency. The Criminal Investigation Command's procurement aligns with CID's forensic laboratory operations, where Qiagen's molecular diagnostics capabilities—including DNA extraction systems, next-generation sequencing supplies, and related reagents—are critical to evidence analysis and criminal investigations. Qiagen maintains substantial indefinite delivery contracts and blanket purchase agreements across federal agencies, including a $2.5 million Federal Bureau of Investigation contract and $6.5 million Defense Health Agency agreement, demonstrating the company's specialized competitive standing in the federal molecular diagnostics marketplace.